ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 60.005

Change

+1.70 (+2.91)%

Market Cap

CAD 0.21B

Volume

2.23K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-22 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.91 (+2.52%)

CAD 3.27B
ZWU:CA BMO Covered Call Utilities ETF

+0.15 (+1.38%)

CAD 1.83B
XIT:CA iShares S&P/TSX Capped Informa..

+1.30 (+2.19%)

CAD 0.72B
HTA:CA Harvest Tech Achievers Growth ..

+0.28 (+1.90%)

CAD 0.59B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.26 (+1.16%)

CAD 0.57B
TXF:CA First Asset Tech Giants Covere..

+0.37 (+2.27%)

CAD 0.57B
XHC:CA iShares Global Healthcare (CAD..

+1.19 (+1.93%)

CAD 0.56B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.37 (+1.29%)

CAD 0.35B
CWW:CA iShares Global Water Common Cl..

+1.14 (+2.02%)

CAD 0.30B
HUTL:CA Harvest Equal Weight Global Ut..

+0.52 (+2.96%)

CAD 0.29B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.68% 49% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.68% 49% F 29% F
Trailing 12 Months  
Capital Gain -12.07% 26% F 17% F
Dividend Return 0.71% 26% F 11% F
Total Return -11.35% 23% F 16% F
Trailing 5 Years  
Capital Gain 2.82% 26% F 33% F
Dividend Return 2.85% 21% F 4% F
Total Return 5.67% 11% F 21% F
Average Annual (5 Year Horizon)  
Capital Gain 1.15% 26% F 36% F
Dividend Return 1.57% 14% F 28% F
Total Return 0.42% 26% F 20% F
Risk Return Profile  
Volatility (Standard Deviation) 13.92% 66% D+ 58% F
Risk Adjusted Return 11.27% 11% F 26% F
Market Capitalization 0.21B 62% D 46% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.